2019-11-13T15:01:20-06:00 2019-06-30 953001179 WINDES INC PO BOX 87 LONG BEACH CA 908010087 990 2018-07-01 330841281 PANCREATIC CANCER ACTION NETWORK INC PANC 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 ABIGAIL WINSTON CFO 3107250025 2019-11-12 1 DONITA M JOSEPH P00286656 5624351191 2019-11-12 66.215.11.242 2019-11-12 16:03:48 PS P 5D04C9354A80B93E424F24406112F0168D52D17D 3CA919AE6424416ADDCF7905954DA29A2C5CE3B2 2018 2020-03-31 21:24:44Z JULIE FLESHMAN 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 65170511 0 X WWW.PANCAN.ORG X 1999 CA TO ADVANCE RESEARCH, SUPPORT PATIENTS, AND CREATE HOPE FOR PEOPLE WHO HAVE PANCREATIC CANCER.. 12 11 179 2407 0 96088 53040826 41998702 4100 1004290 661178 868740 -1762547 -2171450 51943557 41700282 4076081 5818967 0 0 13377470 15562510 0 0 3709880 15396151 14596577 32849702 35978054 19093855 5722228 56135611 65075415 13300815 16038137 42834796 49037278 X THE PANCREATIC CANCER ACTION NETWORK (PANCAN) IS DEDICATED TO FIGHTING THE WORLD'S TOUGHEST CANCER. IN OUR URGENT MISSION TO SAVE LIVES, WE ATTACK PANCREATIC CANCER ON ALL FRONTS: RESEARCH, CLINICAL INITIATIVES, PATIENT SERVICES AND ADVOCACY. OUR EFFORT IS AMPLIFIED BY A NATIONWIDE NETWORK OF GRASSROOTS SUPPORT. WE ARE DETERMINED TO IMPROVE PATIENT OUTCOMES TODAY AND DOUBLE SURVIVAL BY 2020. 0 0 15837193 5854000 1000000 RESEARCH GRANTS AND CLINICAL INITIATIVES - PANCAN'S RESEARCH GRANTS AND CLINICAL INITIATIVES ARE CHANGING THE LANDSCAPE OF PANCREATIC CANCER RESEARCH. THE RESEARCH GRANTS DEPARTMENT ADMINISTERS A COMPETITIVE GRANTS PROGRAM, AWARDING THE MOST MERITORIOUS RESEARCH PROJECTS WITH A FOCUS ON THOSE THAT ADVANCE OUR CLINICAL INITIATIVES, TO THE BRIGHTEST SCIENTISTS, TO TRANSLATE THE BEST RESEARCH INTO THE CLINIC. TO DATE THE GRANTS PROGRAM HAS FUNDED 174 GRANTS, TOTALING NEARLY $47.7M IN FUNDING, WHICH WAS DISTRIBUTED TO 170 SCIENTISTS AT 65 INSTITUTIONS. GROUNDBREAKING INITIATIVES LIKE OUR "KNOW YOUR TUMOR" PRECISION MEDICINE SERVICE, AND PRECISION PROMISE, AN INNOVATIVE CLINICAL TRIAL PLATFORM FOR PATIENTS WITH PANCREATIC CANCER, PLAY A PIVOTAL ROLE IN CHANGING OUTCOMES FOR PATIENTS. IN ADDITION, AGREEMENTS OF THE PRECISION PROMISE AND EARLY DETECTION INITIATIVE PROGRAMS TOTALING NEARLY $2.7M HAVE BEEN INCLUDED IN RESEARCH FOR THIS FISCAL YEAR. 1153154 4290 GOVERNMENT AFFAIRS AND ADVOCACY - WE DRIVE LEGISLATIVE SUPPORT FOR INCREASED FEDERAL RESEARCH FUNDING - CRITICAL BECAUSE APPROXIMATELY 80 PERCENT OF ALL PANCREATIC CANCER RESEARCH FUNDING COMES FROM THE FEDERAL GOVERNMENT. WE LED THE TIRELESS FIGHT TO SUCCESSFULLY PASS THE RECALCITRANT CANCER RESEARCH ACT IN CONGRESS, MAKING PANCREATIC CANCER A NATIONAL PRIORITY, AND THE 21ST CENTURY CURES ACT, WHICH MAKES IT POSSIBLE FOR CONGRESS TO DIRECT MORE FUNDING TO CANCER RESEARCH. ALONG WITH OUR SUPPORTERS, WE HAVE CREATED A GRASSROOTS MOVEMENT - TELLING OUR STORIES TO CONGRESS IN AN EFFORT TO RAISE MORE AWARENESS ABOUT PANCREATIC CANCER, AND IN TURN, THE CRITICAL NEED FOR MORE RESEARCH FUNDING. AS OF 2017, NCI FUNDING FOR PANCREATIC CANCER RESEARCH HAD INCREASED TO MORE THAN $177 MILLION. 3748725 PATIENT SERVICES (PATIENT CENTRAL) - PATIENT CENTRAL IS A COMPREHENSIVE SERVICE PROVIDING IMMEDIATE AND FREE INFORMATION AND EDUCATION ABOUT PANCREATIC CANCER, DIAGNOSIS, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP THEM MAKE INFORMED DECISIONS WITH THEIR HEALTHCARE TEAM. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE PATIENTS WITH PERSONALIZED CLINICAL TRIAL SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR PATIENT CENTRAL STAFF - MADE UP OF EXPERT, UNDERSTANDING, COMPASSIONATE PEOPLE - SHARES MORE RESOURCES AND SPEAKS WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER CANCER ORGANIZATION IN THE WORLD. OUR PATIENT REGISTRY, AN ACTIVE DATABASE OF PATIENT INFORMATION, WAS DEVELOPED TO HELP ADVANCE RESEARCH AND IMPROVE CARE FOR PATIENTS BATTLING PANCREATIC CANCER. 8013690 56858 COMMUNITY ENGAGEMENT - WITH 59 AFFILIATES AND A VOLUNTEER CORPS OF MORE THAN 8,000 PEOPLE, WE RAISE FUNDS AND NATIONAL AWARENESS OF THE DISEASE THROUGH OUR PURPLESTRIDE RUN/WALK EVENTS IN COMMUNITIES NATIONWIDE. OVER 92,000 PARTICIPANTS HAVE ATTENDED OUR SIGNATURE EVENTS THIS PAST YEAR. OUR GRASSROOTS EFFORTS HARNESS THE PASSION, POWER AND ENERGY OF DEDICATED VOLUNTEERS - MANY OF WHOM HAVE LOST LOVED ONES TO THE DISEASE AND ARE COMMITTED TO FIGHTING BACK. OUR ADVOCACY EFFORTS HAVE ALSO RESULTED IN A GLOBAL MOVEMENT - WE PLAYED A LEAD ROLE IN THE CREATION OF THE WORLD PANCREATIC CANCER COALITION WHICH IS COMPOSED OF MORE THAN 80 PANCREATIC CANCER PATIENT GROUPS FROM MORE THAN 30 COUNTRIES ON 6 CONTINENTS. THE COALITION HAS TWO MAJOR INITIATIVES - A GLOBAL DAY OF AWARENESS THAT TAKES PLACE ON THE THIRD THURSDAY OF NOVEMBER, PANCREATIC CANCER AWARENESS MONTH, AND AN ANNUAL FACE-TO-TACE MEETING FOR COALITION MEMBERS TO NETWORK, SHARE EXPERIENCES AND BEST PRACTICES. 8013690 56858 28752762 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 105 0 1 179 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 X 12 11 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY HI X X THOMAS V CROAL CFO 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 JULIE FLESHMAN PRES. & CEO/DIR./EX-OFFICIO 50.00 X X 501477 0 21221 JEANNE WEAVER RUESCH CHAIRMAN 2.00 X X 0 0 0 HILARIE KOPLOW-MC ADAMS VICE CHAIRMAN 2.00 X X 0 0 0 STUART RICKERSON SECRETARY 2.00 X X 0 0 0 PETER CASHION BOARD MEMBER 2.00 X 0 0 0 SCOTT A GRISWOLD CPA BOARD MEMBER 2.00 X 0 0 0 BARBARA J KENNER PHD BOARD MEMBER 2.00 X 0 0 0 MICHAEL AG KORENGOLD BOARD MEMBER 2.00 X 0 0 0 JASON KUHN BOARD MEMBER 2.00 X 0 0 0 TERRENCE MECK BOARD MEMBER 2.00 X 0 0 0 CRAIG A ROGERSON BOARD MEMBER 2.00 X 0 0 0 KAREN YOUNG CPA BOARD MEMBER 2.00 X 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 50.00 X 303261 0 23679 VICTORIA MANAX CHIEF MEDICAL OFFICER 50.00 X 332834 0 19035 SUDHEER DOSS CHIEF DATA OFFICER 50.00 X 316912 0 11439 RICHARD LEONARD CHIEF GIFT OFFICER 50.00 X 242683 0 22598 MICHAEL ROSEN FORMER CHIEF COMMUNICATIONS OFFICER 50.00 X 229345 0 16599 JENNY ISAACSON VP, STRATEGIC PARTNERSHIPS 50.00 X 179566 0 16818 PAMELA MARQUARDT FOUNDER 50.00 X 173584 0 7741 ABIGAIL WINSTON FORMER CFO/COO 50.00 X 224404 0 20111 2504066 0 159241 27 1 1 0 AACR DEVELOPMENT DEPT 615 CHESTNUT ST PHILADELPHIA PA 19106 GRANT PEER REVIEW AND ADMIN 1981500 BERRY CONSULTANTS LLC 3345 BEE CAVES RD SUITE 201 AUSTIN TX 78746 PRECISION PROMISE STRATEGY DEVELOPMENT 1075812 PERSONALIZED CANCER THERAPY 1616 ANDERSON RD MCLEAN VA 22102 CLINICAL RESEARCH 792834 CI PARTNERS DIRECT 1601 EASTMAN AVE SUITE 202 VENTURA CA 93003 DIRECT RESPONSE FUNDRAISING CONSULTANT 657789 FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 MAILSTOP J6-500 SEATTLE WA 98109 CLINICAL RESEARCH 654068 33 168510 16977798 24852394 368958 41998702 PATIENT SERVICES 900099 1000000 1000000 GOV'T AFFAIRS AND ADVOCACY 900099 4290 4290 1004290 887064 887064 21146018 2072 21161831 4583 -15813 -2511 -18324 -18324 18480 16977798 2247238 -2228758 -2228758 113435 56577 56858 56858 OTHER INCOME 900099 450 450 450 41700282 1061148 0 -1359568 X 5818967 5818967 1366205 970663 213166 182376 12129607 8617442 1893360 1618805 388845 276502 60216 52127 767907 546048 118916 102943 909946 647050 140912 121984 120131 69784 36811 13536 35375 20549 10840 3986 232229 232229 140447 140447 5608345 5112608 123870 371867 633349 587203 13712 32434 723977 260928 17048 446001 784807 567424 118939 98444 1320522 935542 205808 179172 688643 570494 3511 114638 1684614 1593394 91220 782928 707210 40479 35239 163839 130107 18033 15699 UNRELATED BUSINESS INCO 33140 18113 10987 4040 BANK AND PROCESSING FEE 897064 634214 141387 121463 STAFF SUPPORT 445689 317150 51903 76636 MISCELLANEOUS 145972 57770 54321 33881 155506 61371 9526 84609 35978054 28752762 3515412 3709880 1470601 11693111 4409417 8187638 23987986 20603233 471546 298326 33984 33467 477296 610114 5251462 3738841 2171771 1512621 22948400 21969853 164610 167052 56135611 65075415 2971172 4017947 9826906 11519592 502737 500598 13300815 16038137 X 16241678 24661755 26593118 24375523 42834796 49037278 56135611 65075415 5722228 480254 0 X 0 1 X 1 0 X 38414247 34319563 35758286 53040826 41998701 203531623 38414247 34319563 35758286 53040826 41998701 203531623 52210493 151321130 404154 453860 423003 553922 887064 2722003 14854 450 15304 206268930 1441228 0.73360 0.73630 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 59150 173079 232229 32270892 32503121 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 235587 249503 16895 232229 734214 250000 250000 250000 250000 1000000 1500000 49094 47215 6870 59150 162329 SCHEDULE C, PART II-A OFFICE IN WASHINGTON DC ENGAGES IN DEVELOPING REPORT LANGUAGE FOR APPROPRIATIONS BILLS; DEVELOPING ALERTS TO OUR MEMBERS REGARDING SPECIFIC LEGISLATION; PREPARING FOR AND ATTENDING VISITS ON CAPITAL HILL BY OUR MEMBERS AND THE PUBLIC DURING ADVOCACY DAYS; GIVING UNINVITED AND INVITED TESTIMONY OR WRITTEN RESPONSES DURING LEGISLATIVE HEARINGS; DEVELOPING GENERAL EDUCATION MESSAGES THROUGH MEDIA CAMPAIGNS THAT DO OR DO NOT INCLUDE A CALL FOR ACTION. 843288 569399 273889 1144974 934672 210302 3263200 2234770 1028430 1512621 CAPITAL LEASE OBLIGATIONS 6854 DEFERRED LEASE LIABILITY 493744 500598 X 42040089 480254 480254 41559835 140447 140447 41700282 35837607 0 35837607 140447 140447 35978054 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE LAWS. IN DECEMBER 2017, THE TAX CUTS AND JOBS ACT (THE ACT) WAS ENACTED, WHICH MAY RESULT IN ADDITIONAL UNRELATED BUSINESS TAXABLE INCOME ON CERTAIN FRINGE BENEFITS. THE ORGANIZATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS FILING STATUS OF TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE ORGANIZATION HAD NO MATERIAL NET UNRELATED BUSINESS INCOME REQUIRING RECOGNITION FOR THE YEARS ENDED JUNE 30, 2019 AND 2018. THE ORGANIZATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND CALIFORNIA STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. X 1 CI PARTNERS DIRECT INC 1601 EASTMAN AVENUE SUITE 202 VENTURA CA 93003 FUNDRAISING CONSULTANT & DIRECT MAIL SERVICES 0 0 18000 0 18000 WALKS AND RUNS 16445017 16445017 1983226 GALA 551261 532781 18480 33422 45977 1600 183013 16996278 16977798 18480 33422 45977 1600 2166239 2247238 -2228758 SCHEDULE G, PART I, LINE 3 THE ORGANIZATION IS REGISTERED TO FUNDRAISE IN EVERY STATE. IN FISCAL YEAR 2019, THE PROPER STATE REGISTRATION FORMS WERE FILED. 1 REGENTS OF THE UNIVERSITY OF MINNESOTA-TWIN CITIES 450 MCNAMARA ALUMNI CENTER 200 OAK STREET SE MINNEAPOLIS MN 55455 416007513 501(C)(3) 500000 FUND RESEARCH SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 N TORREY PINES ROAD LA JOLLA CA 92037 952160097 501(C)(3) 200000 FUND RESEARCH BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1500 DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 500000 FUND RESEARCH SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE 10901 NORTH TORREY PINES ROAD LA JOLLA CA 92037 510197108 501(C)(3) 500000 FUND RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 500000 FUND RESEARCH BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 500000 FUND RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO 3333 CALIFORNIA STREET SUITE 315 SAN FRANCISCO CA 94118 946036493 501(C)(3) 500000 FUND RESEARCH FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 135000 CLINICAL TRIALS RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BOULEVARD 65 WIL SUITE 1150 LOS ANGELES CA 90048 951644600 501(C)(3) 135000 CLINICAL TRIALS RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 135000 CLINICAL TRIALS RESEARCH UNIVERSITY OF FLORIDA 219 GRINTER HALL GAINESVILLE FL 32611 596002052 501(C)(3) 120000 CLINICAL TRIALS RESEARCH JOHNS HOPKINS MEDICINE 733 NORTH BROADWAY SUITE 117 BALTIMORE MD 21202 520595110 501(C)(3) 135000 CLINICAL TRIALS RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 022155450 042263040 501(C)(3) 120000 CLINICAL TRIALS RESEARCH UNIVERSITY OF CHICAGO 5841 S MARYLAND AVENUE ROOM M425 CHICAGO IL 60637 362177139 501(C)(3) 120000 CLINICAL TRIALS RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 3333 CALIFORNIA STREET SUITE 315 SAN FRANCISCO CA 94118 946036493 501(C)(3) 120000 CLINICAL TRIALS RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 3855 HEALTH SCIENCES DRIVE LA JOLLA CA 92093 956006144 501(C)(3) 135000 CLINICAL TRIALS RESEARCH WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN SAINT LOUIS 660 SOUTH EUCLID AVENUE ST LOUIS MO 63110 430653611 501(C)(3) 120000 CLINICAL TRIALS RESEARCH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET P-221 FB PHILADELPHIA PA 19104 231352685 501(C)(3) 135000 CLINICAL TRIALS RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 135000 CLINICAL TRIALS RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE ONE PARK AVENUE 6TH FLOOR NEW YORK NY 10016 135562308 501(C)(3) 120000 CLINICAL TRIALS RESEARCH BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON 1201 NINTH AVENUE SEATTLE WA 98101 910653422 501(C)(3) 120000 CLINICAL TRIALS RESEARCH FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 467000 EARLY DETECTION RESEARCH CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC 401 WEST 15TH STREET SUITE 800 AUSTIN TX 78701 043503931 501(C)(3) 402000 DATA STANDARDS RESEARCH 23 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. SCHEDULE I, PART II GRANTS REPORTED ON SCHEDULE I, PART II ARE GREATER THAN GRANTS REPORTED ON FORM 990, PART IX, LINE 1 DUE TO PRIOR YEAR GRANT REFUNDS. FORM 990, PART IX, LINE 1 IS A NET AMOUNT OF CURRENT YEAR GRANTS AND PRIOR YEAR GRANT REFUNDS. SCHEDULE I, PART II TOTAL GRANTS 5,854,000 PRIOR YEAR GRANT REFUNDS (33,033) ------------- FORM 990, PART IX, LINE 1 GRANTS 5,818,967 X X X X X X 0 1 0 0 0 0 0 0 0 JULIE FLESHMAN PRES. & CEO/DIR./EX-OFFICIO 352555 0 143172 0 5750 0 14363 0 6858 0 522698 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 269205 0 34056 0 0 0 10953 0 12726 0 326940 0 0 0 VICTORIA MANAX CHIEF MEDICAL OFFICER 292671 0 40163 0 0 0 12600 0 6435 0 351869 0 0 0 SUDHEER DOSS CHIEF DATA OFFICER 254029 0 62883 0 0 0 7583 0 3856 0 328351 0 0 0 RICHARD LEONARD CHIEF GIFT OFFICER 215443 0 27240 0 0 0 9216 0 13382 0 265281 0 0 0 MICHAEL ROSEN FORMER CHIEF COMMUNICATIONS OFFICER 197431 0 31914 0 0 0 7899 0 8700 0 245944 0 0 0 JENNY ISAACSON VP, STRATEGIC PARTNERSHIPS 162478 0 17088 0 0 0 7227 0 9591 0 196384 0 0 0 PAMELA MARQUARDT FOUNDER 160868 0 12716 0 0 0 6510 0 1231 0 181325 0 0 0 ABIGAIL WINSTON FORMER CFO/COO 198904 0 25500 0 0 0 8120 0 11991 0 244515 0 0 0 X 1 18000 FMV X 7104 FMV X 30 109051 FMV X 13 32212 FMV X SPORT & ENTERTAINMENT TICKETS 15 116390 FMV X TANGIBLE GOODS, GIFT CARDS 60 75801 FMV 0 1 0 PART I, COLUMN (B): THE NUMBER IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE AUDIT AND INVESTMENT COMMITTEE ("AIC") RECEIVES AND REVIEWS THE DRAFT OF THE FORM 990, INCLUDING SCHEDULES, PRIOR TO THE FILING OF THE RETURN. A MEETING OF THE AIC, INCLUDING THE PRESIDENT AND CEO, THE CFO, THE CONTROLLER, AND THE OUTSIDE CPA FIRM, IS THEN HELD TO REVIEW AND REVISE AS NECESSARY THE DRAFT OF THE FORM 990. UPON APPROVAL OF THE DRAFT FORM 990 BY THE AIC, THE FINAL FORM 990, WITH CHANGES REFLECTED, IF ANY, IS E-MAILED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING FOR ITS REVIEW. UPON ITS APPROVAL, THE FINAL FORM 990 IS FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT AN UPDATED CONFLICT OF INTEREST STATEMENT ON AN ANNUAL BASIS. TO THE EXTENT THAT RELATIONSHIPS ARE IDENTIFIED VIA THESE STATEMENTS AND OTHER INFORMATION, THE INDIVIDUAL'S CONSTITUENT RECORD IN THE COMPANY DATA BASE IS UPDATED TO INCLUDE THIS INFORMATION, FACILITATING PERIODIC QUERIES, AS NECESSARY. THE MEMBER WITH A CONFLICT MUST IDENTIFY THE CONFLICT AT ANY BOARD MEETING WHERE THE CONFLICT IS RELEVENT. THE MEMBER CANNOT BE PRESENT AT ANY PART OF THE MEETING WHERE THE RELEVENT TOPIC IS DISCUSSED OR VOTED ON. THE MEMBER CANNOT BE COUNTED FOR A QUORUM. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD COMPENSATION COMMITTEE IS RESPONSIBLE FOR THE REVIEW AND APPROVAL OF TOP-LEVEL EXECUTIVE MANAGEMENT COMPENSATION ANNUALLY. THE CHIEF PEOPLE OFFICER STAYS ABREAST OF INDUSTRY SALARY LEVELS AND ALERTS THE COMMITTEE TO ANY CHANGE IN SALARY LEVELS. INDEPENDENT PROFESSIONAL EXPERTS ARE CALLED UPON FOR HIGHER-LEVEL POSITIONS AND ASSIST IN ESTABLISHING EXECUTIVE SALARIES IN THE COMPETITIVE MARKETPLACE. SALARIES IN BOTH FOR PROFIT AND NOT FOR PROFIT ORGANIZATIONS ARE EVALUATED IN ORDER TO ATTRACT THE MOST TALENTED PERSONNEL. INFORMATION IS GATHERED, ANALYZED AND REPORTED TO THE COMMITTEE PRIOR TO THEIR MEETINGS ON COMPENSATION WITH THE INTENT OF ENSURING THAT THE EXECUTIVE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE REVIEW INCLUDES INCENTIVE PLANS AND ALL FRINGE BENEFITS AS WELL AS BASE SALARY ARRANGEMENTS. THE BOARD ESTABLISHES THE CEO/PRESIDENT SALARY LEVEL DURING THE EXECUTIVE SESSION OF A CALLED BOARD MEETING. ONCE APPROVED, EXECUTIVE COMPENSATION PACKAGES ARE FORMALIZED IN WRITING AND ONCE ACCEPTED BY THE EXECUTIVE, RETAINED IN THE EXECUTIVES' PERSONNEL FILE(S). FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION HAS A FORMAL POLICY FOR PUBLIC DISCLOSURE AND INSPECTION OF DOCUMENTS. THE POLICY IS POSTED ON THE ORGANIZATION'S WEB-SITE. FORM 990, PART IX, LINE 11G CLINICAL RESEARCH: PROGRAM SERVICE EXPENSES 3,638,608. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 3,638,608. PROFESSIONAL FEES - RECRUITMENT AND HR: PROGRAM SERVICE EXPENSES 234,462. MANAGEMENT AND GENERAL EXPENSES 19,703. FUNDRAISING EXPENSES 59,151. TOTAL EXPENSES 313,316. PROFESSIONAL FEES - GRAPHIC AND WEB DESIGN: PROGRAM SERVICE EXPENSES 283,242. MANAGEMENT AND GENERAL EXPENSES 23,803. FUNDRAISING EXPENSES 71,458. TOTAL EXPENSES 378,503. PROFESSIONAL FEES - TECHNOLOGY: PROGRAM SERVICE EXPENSES 259,049. MANAGEMENT AND GENERAL EXPENSES 21,770. FUNDRAISING EXPENSES 65,354. TOTAL EXPENSES 346,173. PROFESSIONAL FEES - PAYROLL AND ADMINISTRATION: PROGRAM SERVICE EXPENSES 16,510. MANAGEMENT AND GENERAL EXPENSES 1,387. FUNDRAISING EXPENSES 4,165. TOTAL EXPENSES 22,062. PROFESSIONAL FEES - MEDIA PRODUCTION: PROGRAM SERVICE EXPENSES 487,280. MANAGEMENT AND GENERAL EXPENSES 40,949. FUNDRAISING EXPENSES 122,933. TOTAL EXPENSES 651,162. PROFESSIONAL FEES - 401K AUDIT: PROGRAM SERVICE EXPENSES 8,980. MANAGEMENT AND GENERAL EXPENSES 755. FUNDRAISING EXPENSES 2,265. TOTAL EXPENSES 12,000. PROFESSIONAL FEES - OTHER: PROGRAM SERVICE EXPENSES 184,477. MANAGEMENT AND GENERAL EXPENSES 15,503. FUNDRAISING EXPENSES 46,541. TOTAL EXPENSES 246,521. FORM 990 PART VI, LINE 10B COMPANY "AFFILIATES" CONSIST OF VOLUNTEERS WHO AGREE TO PERFORM THEIR VOLUNTEER ACTIVITIES IN COMPLIANCE WITH GUIDELINES PROVIDED IN A COMMUNITY OUTREACH AFFILIATE AGREEMENT. THERE ARE NO NON-VOLUNTEER AFFILIATES, CHAPTERS OR BRANCHES (E.G., NO LEGAL ENTITIES). FORM 990, PART VIII, LINE 8C THE PANCREATIC CANCER ACTION NETWORK AND THEIR NETWORK OF VOLUNTEER AFFILIATES HELD WALKS, RUNS, AND BIKE EVENTS ALL OVER THE NATION TO BOTH FUNDRAISE AND RAISE PUBLIC AWARENESS ABOUT PANCREATIC CANCER. ALL REVENUE RAISED FROM THE EVENTS ARE CONSIDERED TO BE CHARITABLE CONTRIBUTIONS. THE ENTITY DOES INCUR EXPENSES IN CONDUCTING THE EVENTS, BUT BECAUSE ALL INCOME IS CATEGORIZED AS CONTRIBUTION REVENUE, IT IS REPORTED AS A LOSS FROM SPECIAL EVENTS, EVEN THOUGH THE EVENT WAS PROFITABLE.